Samer Nashef of Papworth Hospital, Cambridge, United Kingdom, discusses the AMAZE trial, a double-blind study evaluating the survival and quality of life of patients who receive concomitant maze procedures, and the overall cost-effectiveness of these procedures.
This presentation was originally given during the SCTS Ionescu University program at the 80th Annual Meeting of the Society for Cardiothoracic Surgery in Great Britain and Ireland. This content is published with the permission of SCTS. Please click here for information on the 2015 ACTA/SCTS Annual Meeting & Forum in Manchester, United Kingdom.
